Rao V, Cox Z, Ivey-Miranda J, Neville D, Balkcom N, Moreno-Villagomez J
J Am Soc Nephrol. 2024; 36(1):99-107.
PMID: 39196651
PMC: 11706557.
DOI: 10.1681/ASN.0000000000000481.
Karedath J, Asif A, Tentu N, Zahra T, Batool S, Sathish M
Cureus. 2023; 15(2):e34758.
PMID: 36909062
PMC: 10005852.
DOI: 10.7759/cureus.34758.
Koh S, Jeong J, Choi S, Kim R, Koo T, Cho K
BMC Vet Res. 2021; 17(1):295.
PMID: 34488750
PMC: 8420016.
DOI: 10.1186/s12917-021-02998-4.
Britz H, Hanke N, Taub M, Wang T, Prasad B, Fernandez E
Pharm Res. 2020; 37(12):250.
PMID: 33237382
PMC: 7688195.
DOI: 10.1007/s11095-020-02964-z.
Klomjai W, Lackmy-Vallee A, Katz R, Bussel B, Bensmail D, Lamy J
J Physiol. 2014; 592(13):2865-79.
PMID: 24835171
PMC: 4221825.
DOI: 10.1113/jphysiol.2013.265314.
Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.
Salvador D, Rey N, Ramos G, Punzalan F
Cochrane Database Syst Rev. 2005; (3):CD003178.
PMID: 16034890
PMC: 8094162.
DOI: 10.1002/14651858.CD003178.pub3.
Furosemide disposition in patients on CAPD.
Martin U, Winney R, Prescott L
Eur J Clin Pharmacol. 1995; 48(5):385-90.
PMID: 8641327
DOI: 10.1007/BF00194955.
Plasma protein binding and pharmacological response.
du Souich P, Verges J, Erill S
Clin Pharmacokinet. 1993; 24(6):435-40.
PMID: 8513647
DOI: 10.2165/00003088-199324060-00001.
Influence of drug formulation on drug concentration-effect relationships.
Castaneda-Hernandez G, Caille G, du Souich P
Clin Pharmacokinet. 1994; 26(2):135-43.
PMID: 8162657
DOI: 10.2165/00003088-199426020-00006.
Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments.
Lee S, Lee M, Kim N
J Pharmacokinet Biopharm. 1994; 22(1):1-17.
PMID: 8027946
DOI: 10.1007/BF02353407.
Furosemide dynamics in conscious rabbits: modulation by angiotensin II.
Homsy W, Marleau S, du Souich P
Cardiovasc Drugs Ther. 1995; 9(2):311-7.
PMID: 7662598
DOI: 10.1007/BF00878676.
Furosemide dynamics in conscious rabbits: modulation by arginine vasopressin.
Babini R, du Souich P
Cardiovasc Drugs Ther. 1995; 9(2):305-10.
PMID: 7662597
DOI: 10.1007/BF00878675.
Pharmacokinetics of diuretics and methylxanthines in the neonate.
Aranda J, Turmen T, Sasyniuk B
Eur J Clin Pharmacol. 1980; 18(1):55-63.
PMID: 7398749
DOI: 10.1007/BF00561479.
Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.
Perez J, Sitar D, OGILVIE R
Br J Clin Pharmacol. 1980; 9(5):471-8.
PMID: 7397063
PMC: 1429944.
DOI: 10.1111/j.1365-2125.1980.tb05842.x.
Variability in derived parameters of furosemide pharmacokinetics.
Chennavasin P, Johnson R, Brater D
J Pharmacokinet Biopharm. 1981; 9(5):623-33.
PMID: 7334462
DOI: 10.1007/BF01061029.
Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
Keller E, HOPPE-SEYLER G, Mumm R, Schollmeyer P
Eur J Clin Pharmacol. 1981; 20(1):27-33.
PMID: 7308269
DOI: 10.1007/BF00554663.
Assessment of natriuretic drugs.
Roberts C, Daneshmend T
Br J Clin Pharmacol. 1981; 12(4):465-74.
PMID: 7295482
PMC: 1401899.
DOI: 10.1111/j.1365-2125.1981.tb01252.x.
Human plasma vasopressin response to potent loop-diuretic drugs.
Baylis P, de Beer F
Eur J Clin Pharmacol. 1981; 20(5):343-6.
PMID: 7286044
DOI: 10.1007/BF00615403.
Determinants of the diuretic response to furosemide in infants with congestive heart failure.
Green T, Mirkin B
Pediatr Cardiol. 1982; 3(1):47-51.
PMID: 7155939
DOI: 10.1007/BF02082332.
Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
Riva E, Fossali E, Bettinelli A
Eur J Clin Pharmacol. 1982; 21(4):303-6.
PMID: 7056274
DOI: 10.1007/BF00637617.
